Gelmini, S.; Calabri, A.; Mancini, I.; Comin, C.E.; Pasini, V.; Banini, M.; Scotti, V.; Pinzani, P.
Circulating Tumor Cell-Free DNA as Prognostic Biomarker in Non-Small Cell Lung Cancer Patients Undergoing Immunotherapy: The CORELAB Experience. Int. J. Mol. Sci. 2025, 26, 611.
https://doi.org/10.3390/ijms26020611
AMA Style
Gelmini S, Calabri A, Mancini I, Comin CE, Pasini V, Banini M, Scotti V, Pinzani P.
Circulating Tumor Cell-Free DNA as Prognostic Biomarker in Non-Small Cell Lung Cancer Patients Undergoing Immunotherapy: The CORELAB Experience. International Journal of Molecular Sciences. 2025; 26(2):611.
https://doi.org/10.3390/ijms26020611
Chicago/Turabian Style
Gelmini, Stefania, Adele Calabri, Irene Mancini, Camilla Eva Comin, Valeria Pasini, Marco Banini, Vieri Scotti, and Pamela Pinzani.
2025. "Circulating Tumor Cell-Free DNA as Prognostic Biomarker in Non-Small Cell Lung Cancer Patients Undergoing Immunotherapy: The CORELAB Experience" International Journal of Molecular Sciences 26, no. 2: 611.
https://doi.org/10.3390/ijms26020611
APA Style
Gelmini, S., Calabri, A., Mancini, I., Comin, C. E., Pasini, V., Banini, M., Scotti, V., & Pinzani, P.
(2025). Circulating Tumor Cell-Free DNA as Prognostic Biomarker in Non-Small Cell Lung Cancer Patients Undergoing Immunotherapy: The CORELAB Experience. International Journal of Molecular Sciences, 26(2), 611.
https://doi.org/10.3390/ijms26020611
